TY - JOUR
T1 - Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins
AU - Kouton, Ludivine
AU - Boucraut, José
AU - Devaux, Jérome
AU - Rajabally, Yusuf A.
AU - Adams, David
AU - Antoine, Jean Christophe
AU - Bourdain, Frédéric
AU - Brodovitch, Alexandre
AU - Camdessanché, Jean Philippe
AU - Cauquil, Cécile
AU - Ciron, Jonathan
AU - Dubard, Thierry
AU - Echaniz-Laguna, Andoni
AU - Grapperon, Aude Marie
AU - Juntas-Morales, Raul
AU - Kremer, Laurent
AU - Kuntzer, Thierry
AU - Labeyrie, Céline
AU - Lanfranco, Luca
AU - Léger, Jean Marc
AU - Maisonobe, Thierry
AU - Mavroudakis, Nicolas
AU - Mecharles-Darrigol, Sylvie
AU - Merle, Philippe
AU - Noury, Jean Baptiste
AU - Rouaud, Violaine
AU - Tard, Céline
AU - Théaudin, Marie
AU - Vallat, Jean Michel
AU - Viala, Karine
AU - Attarian, Shahram
AU - Delmont, Emilien
N1 - Publisher Copyright:
© 2020 International Federation of Clinical Neurophysiology
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Objective: Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with antibodies against neurofascin 155 (Nfasc155) or contactin-1 (CNTN1) have distinctive clinical features. Knowledge on their electrophysiological characteristics is still scarce. In this study, we are investigating whether these patients have specific electrophysiological characteristics. Methods: The electrophysiological data from 13 patients with anti-Nfasc155 IgG4 antibodies, 9 with anti-CNTN1 IgG4 antibodies were compared with those of 40 consecutive CIDP patients without antibodies. Results: All the patients with antibodies against Nfasc155 or CNTN1 fulfilled the EFNS/PNS electrodiagnostic criteria for definite CIDP. There was no electrophysiological difference between patients with anti-CNTN1 and anti-Nfasc155 antibodies. Nerve conduction abnormalities were heterogeneously distributed along nerves trunks and roots. They were more pronounced than in CIDP without antibodies. Motor conduction velocity on median nerve <24 m/s or motor velocity on ulnar nerve <26 m/s or motor distal latency on ulnar nerve >7.4 ms were predictive of positive antibodies against the node of Ranvier with a sensitivity of 59% and a specificity of 93%. Conclusions: Marked conduction abnormalities may suggest the presence of positive antibodies against the node of Ranvier. Significance: Anti-Nfasc155 and anti-CNTN1 antibodies target the the paranodal axo-glial domain but are associated with nerve conduction abnormalities mimicking a “demyelinating” neuropathy.
AB - Objective: Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with antibodies against neurofascin 155 (Nfasc155) or contactin-1 (CNTN1) have distinctive clinical features. Knowledge on their electrophysiological characteristics is still scarce. In this study, we are investigating whether these patients have specific electrophysiological characteristics. Methods: The electrophysiological data from 13 patients with anti-Nfasc155 IgG4 antibodies, 9 with anti-CNTN1 IgG4 antibodies were compared with those of 40 consecutive CIDP patients without antibodies. Results: All the patients with antibodies against Nfasc155 or CNTN1 fulfilled the EFNS/PNS electrodiagnostic criteria for definite CIDP. There was no electrophysiological difference between patients with anti-CNTN1 and anti-Nfasc155 antibodies. Nerve conduction abnormalities were heterogeneously distributed along nerves trunks and roots. They were more pronounced than in CIDP without antibodies. Motor conduction velocity on median nerve <24 m/s or motor velocity on ulnar nerve <26 m/s or motor distal latency on ulnar nerve >7.4 ms were predictive of positive antibodies against the node of Ranvier with a sensitivity of 59% and a specificity of 93%. Conclusions: Marked conduction abnormalities may suggest the presence of positive antibodies against the node of Ranvier. Significance: Anti-Nfasc155 and anti-CNTN1 antibodies target the the paranodal axo-glial domain but are associated with nerve conduction abnormalities mimicking a “demyelinating” neuropathy.
KW - CIDP
KW - Contactin 1
KW - Electrophysiology
KW - Neurofascin 155
UR - https://www.scopus.com/pages/publications/85079417841
UR - https://www.sciencedirect.com/science/article/abs/pii/S1388245720300407?via%3Dihub
U2 - 10.1016/j.clinph.2020.01.013
DO - 10.1016/j.clinph.2020.01.013
M3 - Article
C2 - 32078921
AN - SCOPUS:85079417841
SN - 1388-2457
VL - 131
SP - 921
EP - 927
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
IS - 4
ER -